Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug-induced Fatty Liver Disease: Pathogenesis and Treatment
Tea Omanović Kolarić, Vjera Ninčević, Lucija Kuna, et al.
Journal of Clinical and Translational Hepatology (2021) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Deep Learning Algorithm Based on Molecular Fingerprint for Prediction of Drug‐Induced Liver Injury
Qiong Yang, Shuwei Zhang, Li Yan
Toxicology (2024) Vol. 502, pp. 153736-153736
Closed Access | Times Cited: 9
A quantitative weight-of-evidence method for confidence assessment of adverse outcome pathway networks: A case study on chemical-induced liver steatosis
A. Verhoeven, J. van Ertvelde, Joost Boeckmans, et al.
Toxicology (2024) Vol. 505, pp. 153814-153814
Closed Access | Times Cited: 9
Targeting collagen homeostasis for the treatment of liver fibrosis: Opportunities and challenges
Theerut Luangmonkong, Warisara Parichatikanond, Peter Olinga
Biochemical Pharmacology (2023) Vol. 215, pp. 115740-115740
Open Access | Times Cited: 20
Treatment of Drug-Induced Liver Injury
Rolf Teschke
Biomedicines (2022) Vol. 11, Iss. 1, pp. 15-15
Open Access | Times Cited: 27
Simultaneous detection of mitochondrial viscosity and peroxynitrite in livers from subjects with drug-induced fatty liver disease using a novel fluorescent probe
Linqiang Niu, Qijuan Cao, Tian Zhang, et al.
Talanta (2023) Vol. 260, pp. 124591-124591
Closed Access | Times Cited: 14
Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review
Fateme Ziamanesh, Mehdi Mohammadi, Sholeh Ebrahimpour, et al.
Journal of Diabetes & Metabolic Disorders (2023) Vol. 22, Iss. 2, pp. 1083-1094
Open Access | Times Cited: 13
Green Tea Polyphenol (-)-Epicatechin Pretreatment Mitigates Hepatic Steatosis in an In Vitro MASLD Model
Marija Hefer, Ana G. Petrovic, Lucija Kuna, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8981-8994
Open Access | Times Cited: 4
Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations
Rolf Teschke
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6663-6663
Open Access | Times Cited: 10
Enhancing DILI Toxicity Prediction through Integrated Graph Attention (GATNN) and Dense Neural Networks (DNN).
Agung Surya Wibowo, Kil To Chong, Hilal Tayara
Toxicology (2025), pp. 154108-154108
Closed Access
Clinical Considerations of Drug-Induced Hepatotoxicity
Melanie Hundt, Mahmoud Galal Moawad Mohamed, Lily Dara
Elsevier eBooks (2025)
Closed Access
Protective potential of bempedoic acid as an AMPK activator in tamoxifen-induced steatohepatitis in rats
M. Mosaad, Elsayed K. El-Sayed, Engy M. El Morsy
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Advanced Strategies in Enhancing the Hepatoprotective Efficacy of Natural Products: Integrating Nanotechnology, Genomics, and Mechanistic Insights
Jitendra Patel, Harekrishna Roy, Pavan Kuma Chintamaneni, et al.
ACS Biomaterials Science & Engineering (2025)
Open Access
Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways
Ernesto López-Pascual, Iván Rienda, Judith Pérez‐Rojas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5203-5203
Open Access | Times Cited: 3
Chronic liver disease and management with silymarin: an introductory review of a clinical case collection
Francesco Angelico
Drugs in Context (2024) Vol. 13, pp. 1-9
Open Access | Times Cited: 2
Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplier
Ashok Choudhury, Ruveena Bhavani Rajaram, Shiv Kumar Sarin
Hepatology International (2024) Vol. 18, Iss. S2, pp. 941-958
Closed Access | Times Cited: 2
Protective Effect of Annona muricata Linn Fruit Pulp Lyophilized Powder against Paracetamol-Induced Redox Imbalance and Hepatotoxicity in Rats
Seema Menon, Rasha A. Al-Eisa, Hamida Hamdi, et al.
Processes (2023) Vol. 11, Iss. 1, pp. 276-276
Open Access | Times Cited: 5
Hepatoprotective Efficacy of Cycloastragenol Alleviated the Progression of Liver Fibrosis in Carbon-Tetrachloride-Treated Mice
Theerut Luangmonkong, Pittaya Puphancharoensuk, Varisara Tongsongsang, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 231-231
Open Access | Times Cited: 4
Celiac Disease and Liver Damage: The Gut–Liver Axis Strikes Back (Again)? A Retrospective Analysis in the Light of a Literature Review
Aurelio Seidita, F Latteri, Mirco Pistone, et al.
Nutrients (2024) Vol. 17, Iss. 1, pp. 85-85
Open Access | Times Cited: 1
Management of non-alcoholic fatty liver disease incidentally detected during other medical assessments
Yeong Yeh Lee, V. Shen
Drugs in Context (2023) Vol. 12, pp. 1-5
Open Access | Times Cited: 3
Exercise Training and Probiotic Lacticaseibacillus rhamnosus GG Reduce Tetracycline-Induced Liver Oxidative Stress and Inflammation in Rats with Hepatic Steatosis
Fariba Aghaei, Ehsan Arabzadeh, Hamideh Mahmoodzadeh Hosseini, et al.
Probiotics and Antimicrobial Proteins (2022) Vol. 15, Iss. 5, pp. 1393-1405
Closed Access | Times Cited: 5
Fatty Liver Change in Korean Adults in a Systematic Social Distancing System Amid the COVID-19 Pandemic: A Multicenter Analysis
Ji-Hee Haam, Yang‐Im Hur, Young‐Sang Kim, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 16, pp. 10444-10444
Open Access | Times Cited: 4
Preclinical Models and Promising Pharmacotherapeutic Strategies in Liver Fibrosis: An Update
Tea Omanović Kolarić, Lucija Kuna, Marina Čović, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 5, pp. 4246-4260
Open Access | Times Cited: 2
4-hydroxylonchocarpin and corylifol A: The potential hepatotoxic components of Psoralea corylifolia L
Linqi Ouyang, Zhiqiang Fan, Yang He, et al.
Toxicology Letters (2023) Vol. 385, pp. 31-41
Closed Access | Times Cited: 2
Non-invasive differentiation of hepatic steatosis and steatohepatitis in a mouse model using nitroxyl radical as an MRI-contrast agent
Yuka Yoshino, Yuta Fujii, Kazuhiro Chihara, et al.
Toxicology Reports (2023) Vol. 12, pp. 1-9
Open Access | Times Cited: 2
Anwulignan Alleviates the Acute Liver Injury Induced by Acetaminophen in Mice
Zhao Chenghe, Wang Yao, Shu Jing, et al.
Pharmacognosy Magazine (2024) Vol. 20, Iss. 2, pp. 656-665
Open Access
Page 1 - Next Page

Scroll to top